Live Breaking News & Updates on York Based Pfizer

Stay updated with breaking news from York based pfizer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Pfizer Wins $107.5M in Cancer Drug Patent Case Against AstraZeneca

Another patent case puts Pfizer under fire. ....

United States , Matthew Kennelly , European Patent Office , York Based Pfizer , Judge Matthew Kennelly ,

Health: Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial

Health: Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial
gdnonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gdnonline.com Daily Mail and Mail on Sunday newspapers.

United States , Matthew Kennelly , York Based Pfizer , Judge Matthew Kennelly ,

Moderna wins COVID shot patent case, Pfizer gets damages in cancer drug patent trial

Pfizer loses against Moderna, but remains winner against AstraZeneca ....

United States , Matthew Kennelly , European Patent Office , Us Patent Office , Financial Times , York Based Pfizer , Judge Matthew Kennelly ,

Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial

Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United States , Blake Brittain , Matthew Kennelly , Puma Biotechnology , York Based Pfizer , Judge Matthew Kennelly , Bill Berkrot ,

Moderna wins a battle in vaccine patent dispute with Pfizer-BioNTech

Moderna wins a battle in vaccine patent dispute with Pfizer-BioNTech
bostonglobe.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bostonglobe.com Daily Mail and Mail on Sunday newspapers.

European Patent Office , York Based Pfizer , Financial Times ,